Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Cadherin 5 Antikörper (pTyr731)

CDH5 Reaktivität: Human, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN1835338

Datenblatt (PDF)

Target Alle Cadherin 5 (CDH5) Antikörper anzeigen

Cadherin 5 (CDH5)
Bindungsspezifität
16

12

7

6

4

3

3

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
pTyr731
Reaktivität
104

65

41

3

2

1

1

1

1

1

1
Human, Maus
Wirt
84

32

9

1
Kaninchen
Passende Sekundärantikörper
Klonalität
83

43
Polyklonal
Konjugat
69

7

7

5

4

4

3

3

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser Cadherin 5 Antikörper ist unkonjugiert
Applikation
84

42

38

37

23

15

15

14

13

13

12

5

5

4

4

4

3

3

2

2

2

1

1

1

1

1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Spezifität

VE-Cadherin (Phospho-Tyr731) Antibody detects endogenous levels of VE-Cadherin only when phosphorylated at tyrosine731.

Kreuzreaktivität

Maus

Aufreinigung

Immunoaffinity purified

Immunogen

Synthetic peptide derived from human VE-Cadherin around the phosphorylation site of Tyr731.
Immunogen type: Synthetic peptide

Isotyp

IgG

Top Product

Discover our top product CDH5 Primärantikörper
anti-Cadherin 5 (CDH5) (AA 601-700) antibody
CDH5 Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, ICC, IHC (p), IHC (fro), IF (p), IF (cc) Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (AA 68-307) antibody
CDH5 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (AA 29-223) antibody
CDH5 Reaktivität: Human, Maus WB, ELISA, FACS Wirt: Maus Monoclonal 3D5C7 unconjugated

anti-Cadherin 5 (CDH5) (AA 29-223) antibody
CDH5 Reaktivität: Human, Ratte WB, ELISA, FACS Wirt: Maus Monoclonal 3D5C7 unconjugated

anti-Cadherin 5 (CDH5) (AA 650-750) antibody
CDH5 Reaktivität: Human WB, IHC, IP, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (C-Term) antibody
CDH5 Reaktivität: Human, Maus WB, IHC, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (AA 26-194) antibody
CDH5 Reaktivität: Human WB, IHC, IP, IF Wirt: Maus Monoclonal 75-Cadherin unconjugated

anti-Cadherin 5 (CDH5) (AA 766-784) antibody
CDH5 Reaktivität: Human, Maus, Ratte WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (AA 59-382) antibody
CDH5 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Cadherin 5 (CDH5) (AA 251-320) antibody
CDH5 Reaktivität: Human, Maus FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Recommended dilution:
ELISA (1 : 20000),
IHC (1 : 50 - 1 : 100),
WB (1 : 500 - 1 : 1000)

Beschränkungen

Nur für Forschungszwecke einsetzbar
Konzentration

Lot specific

Buffer

PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Lagerung

-20 °C
Target

Cadherin 5 (CDH5)

Andere Bezeichnung

CD144 (CDH5 Produkte)

Synonyme

7B4 antikoerper, AA408225 antikoerper, Cd144 antikoerper, VE-Cad antikoerper, VECD antikoerper, VEcad antikoerper, Vec antikoerper, wu:fc88a07 antikoerper, CD144 antikoerper, cadherin-5 antikoerper, cadherin 5 antikoerper, CDH5 antikoerper, Cdh5 antikoerper, cdh5 antikoerper

Hintergrund

Synonyms :
CDH5, 7B4, 7B4 antigen, CD144, Cadherin-5, Endothelial-specific cadherin, Vascular endothelial cadherin, VE-cadherin, VEC, CD144 antigen, VE Cadherin

Gen-ID

1003

UniProt

P33151

Pathways

Cell-Cell Junction Organization, Signaling Events mediated by VEGFR1 and VEGFR2